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Abstract
Background: a-Syntrophin is a scaffolding protein linking signaling proteins to the sarcolemmal dystrophin complex in
mature muscle. However, a-syntrophin is also expressed in differentiating myoblasts during the early stages of muscle
differentiation. In this study, we examined the relationship between the expression of a-syntrophin and myogenin, a key
muscle regulatory factor.
Methods and Findings: The absence of a-syntrophin leads to reduced and delayed myogenin expression. This conclusion is
based on experiments using muscle cells isolated from a-syntrophin null mice, muscle regeneration studies in a-syntrophin
null mice, experiments in Sol8 cells (a cell line that expresses only low levels of a-syntrophin) and siRNA studies in
differentiating C2 cells. In primary cultured myocytes isolated from a-syntrophin null mice, the level of myogenin was less
than 50% that from wild type myocytes (p,0.005) 40 h after differentiation induction. In regenerating muscle, the
expression of myogenin in the a-syntrophin null muscle was reduced to approximately 25% that of wild type muscle
(p,0.005). Conversely, myogenin expression is enhanced in primary cultures of myoblasts isolated from a transgenic mouse
over-expressing a-syntrophin and in Sol8 cells transfected with a vector to over-express a-syntrophin. Moreover, we find
that myogenin mRNA is reduced in the absence of a-syntrophin and increased by a-syntrophin over-expression.
Immunofluorescence microscopy shows that a-syntrophin is localized to the nuclei of differentiating myoblasts. Finally,
immunoprecipitation experiments demonstrate that a-syntrophin associates with Mixed-Lineage Leukemia 5, a regulator of
myogenin expression.
Conclusions: We conclude that a-syntrophin plays an important role in regulating myogenesis by modulating myogenin
expression.
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Introduction
The basic helix-loop-helix family of transcription regulatory
factors is critical for proper development of skeletal muscle. MyoD
and Myf5 are important for myogenic determination while
myogenin and Mrf4 promote terminal differentiation of muscle
precursor cells to mature skeletal muscle. Myogenin regulates the
expression of a myriad of muscle specific genes and is necessary for
normal muscle development [1]. Myogenin knockout mice have a
severe muscle deformity at birth [2–3]. These mice accumulate
myoblasts that are arrested in their terminal differentiation
program. During normal muscle development, myogenin is not
expressed in undifferentiating myoblasts but accumulates at the
onset of differentiation [4]. Expression of myogenin is induced by
factors that stimulate the myogenic program, such as the decrease
in growth factors or presence of insulin-like growth factor-1 (IGF-
1), a potent activator of differentiation [5–8].
a-Syntrophin has been widely studied for its role as a molecular
adapter protein that recruits signaling proteins to the sarcolemmal
dystrophin scaffold in mature muscle. a-Syntrophin binds ion
channels [9–11], G-protein coupled receptors [12], water channels
[13], kinases and associated proteins [14–17], and neuronal nitric
oxide synthase [18].
Nearly all studies of skeletal muscle a-syntrophin have been
performed using mature muscle. Very little is known about the
role of a-syntrophin during early muscle development, even
though myoblasts express a-syntrophin before terminal differen-
tiation [19]. One study has shown that a-syntrophin localizes
diacylglycerol kinase-f (DGKf during several stages of myoblast
fusion [19]. The most compelling evidence for a role of a-
syntrophin in muscle development comes from investigation of
muscle regeneration in a knockout mouse lacking of the a-
syntrophin [20]. Regenerating skeletal muscle in this mouse
showed several defects including fiber splitting, fiber type shifts,
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after regeneration.
The regeneration defects in the absence of a-syntrophin and the
observation that a-syntrophin is present in undifferentiated
myoblasts prompted us to investigate the role of a-syntrophin in
muscle development. In this study we focus on the relationship
between a-syntrophin and myogenin expression. We explore
myogenin expression using in vivo and in vitro systems that vary in
their level of a-syntrophin expression. Furthermore we investigate
the temporal expression and spatial localization of a-syntrophin
during myoblast differentiation to facilitate the understanding of a-
syntrophin’s role in muscle development.
Materials and Methods
Materials
Isoform-specific antibodies to syntrophins were previously
prepared [21]. All other antibodies were purchased as follows;
anti-myogenin from BD Bioscience (San Jose, CA) or Santa Cruz
Biotechnology (Santa Cruz, CA), antibodies to dystrophin and b-
actin from Sigma (St. Louis, MO), anti-MLL-5 antibody from
Orbigen (San Diego, CA), antibodies to GAPDH and actin from
Cell Signaling (Danvers, PA). a-Syntrophin-specific siRNA and
control siRNA were from Santa Cruz Biotechnology (Santa Cruz,
CA). Cardiotoxin (Naja nigricollis) was obtained from Calbiochem
(La Jolla, CA). Rabbit TrueBlot beads and antibody were obtained
from eBioscience (San Diego, CA). All the cell culture reagents,
0.25% Trypsin-EDTA, Lipofectamine 2000 and pcDNA 3.1 were
from Invitrogen (Carlsbad, CA). RNA-SPIN
TM total RNA
extraction kit, Maxim
TM RT premix kit, and other reagents for
RT-PCR were from Intron Biotechnology (Seoul, Korea).
Bradford assay kit for determine of protein concentration was
from Bio-Rad (Hercules, CA).
Cell culture
Primary skeletal muscle cells were isolated from the forelimbs
and hindlimbs of neonatal mice (0–1 d old) from C57BL6 (wild-
type), a-syntrophin knockout (a-KO) [22], a/b2-syntrophin
knockout (aabb) [23] and a-syntrophin transgenic mice (FLA)
[24] strains. The preparation was carried out according to
previously described procedure [25] with slight modifications.
Myoblasts were isolated from minced muscle tissue following
dissociation with 0.25% trypsin-EDTA (final conc. 0.05%) in PBS
for 45 min at 37uC. For myoblast enrichment, cells were passed
through a strainer (80 mm pore size; BD Falcon, San Jose, CA) and
pre-plated twice for 1 h each plating. The percentage of myoblasts
could be maintained at greater that 70% by preplating the cells
[26]. Cells then were seeded at a density of 3.0610
5 cells/ml in
Dulbecco’s modified Eagle’s medium (DMEM) containing 10%
fetal bovine serum (FBS) and 5% new-born calf serum for 1 day
under 5% CO2 at 37uC. Then, cells were transferred into 2%
horse serum (HS) containing DMEM for differentiation induction.
C2 and Sol8 myogenic cells were seeded at a concentration of
1.0610
4 cells/ml. Cells were grown in 10% FBS containing
DMEM (growth medium) for 3 days and induced to differentiate
by transfer into 2% HS containing DMEM (Figure S1).
Experimental procedures performed on mice were approved by
the Institutional Animal Care and Use Committee of the
University of Washington.
Western blot analysis
Cells were rinsed twice with cold phosphate-buffered saline
(PBS), harvested with a scraper and disrupted by ultrasonication in
RIPA buffer, pH 7.4, containing 9.1 mM Na2HPO4, 1.7 mM
NaH2PO4, 150 mM NaCl, 0.5% sodium deoxycholate, 0.1%
SDS, 1 mM PMSF and 0.1% protease inhibitor cocktail (Sigma).
Cell lysates were centrifuged at 15,0006g for 3 min to remove cell
debris and the protein concentration of the supernatant deter-
mined using the Bradford assay. Equal amounts of total protein
(20 g) were resolved by 4–15% gradient or 10% SDS-polyacryl-
amide gel electrophoresis and transferred onto polyvinylidene
difluoride (PVDF) membrane (Millipore, MA). The membranes
were incubated for 1 h in a blocking buffer (Tris-buffered saline
containing 0.1% Tween-20 and 5% non-fat milk) and then
incubated with primary antibodies (1:1000) overnight at 4uC. After
incubation with peroxidase conjugated secondary antibodies, the
immune reactive protein bands were visualized by enhanced
chemiluminescence (ECL) detection with Digital Luminescent
Image Analyzer LAS-1000 (Fuji film, Japan). Band intensity was
determined using Scion image software (Fredrick, MD).
Immunofluorescence analysis
For immunolabeling, cells cultured on coverslips were fixed with
4% paraformaldehyde in PBS for 10 min and permeabilized with
0.5% Triton X-100 in PBS. After blocking with 10% normal goat
serum for 10 min, cells were incubated with anti-a-syntrophin
antibody (1:50 dilution) for 1 h. Cells were then incubated with
propidium iodide (PI) for staining nuclei, and a fluorescent
secondary antibody (1:100 dilution) for 40 min. The specimens
were observed using a Zeiss LSM510 confocal laser scanning
microscope.
Separation of nuclear and cytoplasmic fractions
Cells were washed twice with cold PBS and harvested with a
scraper, and then mixed with nuclear extraction buffer (20 mM
HEPES, pH 7.5, containing 150 mM NaCl, 10% Glycerol, 1 mM
EDTA, 0.5% Triton X-100, 1 mM Na3VO4, 10 mM NaF, 1 mM
PMSF, and 0.01% of protease inhibitor cocktail) and incubated for
30 min on ice. The cell suspension was passed through a 23-gauge
needle 30 times and then centrifuged at 1,0006g for 10 min. The
pellet and supernatant from the centrifugation are referred to as
the nuclear and cytoplasmic fractions, respectively. The nuclear
fraction was washed 3 times with nuclear extraction buffer and
then subjected to ultrasonication.
Transfection of a-syntrophin specific small interference
RNA (siRNA) or cDNA
For siRNA transfection, C2 cells (1.0610
5 cells/ml) were grown
in 24-well tissue culture plates in an antibiotic-free DMEM
containing 10% FBS for 24 h. Cells were transferred into Opti-
MEM and then were transfected by incubation with control
siRNA or a-syntrophin specific siRNA for 6 h. The transfected
cells were transferred into differentiation medium (0 h) and
cultured for the indicated times. For the over-expression of a-
syntrophin, the full-length a-syntrophin cDNA [27] was cloned
into the HindIII and BamHI site of pcDNA3.1. Sol8 cells
(1.0610
5 cells/ml) were cultured in 24-well tissue culture plates in
an antibiotic-free DMEM containing 10% FBS for 24 h. Cells of
90% confluence were incubated with a-syntrophin cDNA in
pcDNA3 and used in transfection experiments with Lipofectamine
2000 according to the manufacturer’s instructions.
RNA preparation and reverse transcriptase (RT)-PCR
Total RNA was isolated from C2 or Sol8 cells using RNA-
SPIN
TM total RNA extraction kit. First strand cDNA synthesis was
performed using 1 g RNA template with the Maxim
TM RT
premix kit according to the manufacturer’s instructions. The
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PCR (30 cycles of 94uC for 30 sec, 59uC for 30 sec and 72uC for
30 sec for a-syntrophin and GAPDH; 30 cycles of 94uC for 30 sec,
55uC for 30 sec and 72uC for 30 sec for myogenin). The primer
sequences used were: mouse a-syntrophin GCTAAAGAGGC-
GAAGATGG and TTATGATAGCTTCAAGGCCA; mouse
myogenin, GCAGTGCCATCCAGTACATTGAGC and GGA-
AGGTGACAGACATATCCTCCAC; mouse GAPDH, ACCA-
CAGTCCATGCCATCAC and TCCACCACCCTGTTGCT-
GTA.
Cardiotoxin injection
Eight week old female C57BL6 (wild-type) and a-KO mice were
anesthetized and 30 ml of cardiotoxin (10 mM in PBS) was injected
into the left tibialis anterior (TA) muscle and the same volume of
PBS was injected into the right TA as a control. At the indicated
time points following injection, the TA muscles were isolated,
frozen in liquid nitrogen and stored at 270uC until use. Each
frozen muscle was added to 2.5 ml of a RIPA buffer and
homogenized using a PT200E Polytron (Kinematica, Luzern,
Switzerland). Muscle lysates were incubated on ice for 30 min, and
then centrifuged 15,000 g for 3 min. The protein concentration of
the supernatant was determined by Bradford assay (Bio-Rad) and
the samples subjected to immunoblot analysis.
Immunoprecipitation
Cells were harvested as above, lysed with a RIPA buffer and
disrupted with an ultrasonicator. To remove cell debris, lysates
were spun down at 15,0006 g for 3 min. For pre-clearance, cell
extracts (500 mg/500 ml) were incubated with 50 ml of TrueBlot
beads for 30 min on ice. Anti-a-syntrophin antibody was then
added to pre-cleared cell lysates and incubated overnight at 4uC.
TrueBlot beads (50 ml) were added again to the extracts and
incubated for 1 h at 4uC. The immune-complexes were collected
by centrifugation, washed 3 times with PBS and separated with
SDS-PAGE.
Statistical analysis
For the statistical analysis of the myogenin level, two-tailed
Student’s unpaired t tests were performed. A value of p,0.01 was
considered to be significant.
Results
Myogenin expression in mouse myocytes
In this work we investigated the role of a-syntrophin in muscle
development focusing on its modulation of myogenin expression.
For the first set of experiments, mononucleated skeletal myoblasts
from a-syntrophin knockout (a-KO) or C57 wild-type mice were
isolated from neonatal pups and grown in culture. In mitogen-rich
growth medium, myoblasts proliferate with no prominent
difference in morphology between the a-KO and controls. Upon
transfer into low-mitogen differentiation medium, myoblasts fuse
to produce multinucleated myotubes. Myogenin is first expressed
during this differentiation into myotubes. We collected samples of
the cultured muscle cells 1, 20, and 40 hrs after the addition of
differentiation medium. Immunoblot analysis shows that in the
undifferentiated myocytes (1 h), myogenin levels are relatively low,
but as differentiation proceeds, the myogenin levels increase
(Figure 1A). At 40 h after differentiation induction, myogenin
levels are approximately four times the level at 1 h. Myogenin
expression in a-KO cells also increases during differentiation but is
consistently lower than that of C57 cells. At 40 h after
differentiation induction, myogenin levels in the a-KO samples
are less than half those of the C57 samples.
To strengthen the correlation between syntrophin and myo-
genin expression, we compared myogenin levels of a-KO
myocytes with those of myocytes derived from a-syntrophin-
transgenic mice (FLA). These mice over-express a-syntrophin in
striated muscle and have been bred onto the a-syntrophin KO
background so that the only a-syntrophin expressed is derived
from the transgene [24]. The level of myogenin in the FLA
myoblasts is more than twice that of a-KO at the first (1 h) time
Figure 1. Expression of myogenin during myocyte differenti-
ation. (A) Primary cultured skeletal muscle cells from wild-type (black
bar) or a-KO (white bar) were harvested at the time points indicated
after differentiation induction. The level of myogenin expression was
determined by western blotting and the band intensity was quantified
using Scion Image. The average band intensity of wild type myocytes at
1 h was defined as 1.00 to express the relative intensity of the
remaining samples. Values are the mean 6 S.E.M. of four independent
experiments. (*p,0.01, **p,0.005). The inset shows a representative
blot. (B) Similar experiments comparing the myogenin expression in a-
KO (white bar) or the a-syntrophin transgenic, FLA (crosshatched bar).
Values are expressed as mean 6 S.E.M. of three independent
experiments. (**p,0.005). Actin immunolabeling was used as a loading
control.
doi:10.1371/journal.pone.0015355.g001
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when myoblasts fusion peaks, there is no significant difference in
myogenin expression. These results indicate that a-syntrophin
expression is correlated with the expression of myogenin during
the early differentiation of cultured skeletal muscle cells.
Myogenin expression in regenerating mouse muscle
Based on our findings in cultured primary myoblasts, we
investigated the relationship between a-syntrophin and myogenin
expression using an in vivo system. Myogenin is down-regulated in
mature muscle fibers [28]. Therefore, we investigated myogenin
expression in regenerating muscle. We induced regeneration by
injecting cardiotoxin directly into the muscle of 8-week-old control
and a-KO mice. Cardiotoxin was injected into the tibialis anterior
(TA) muscle and the contralateral TA was injected with PBS as a
control. Since previous studies showed that myogenic differenti-
ation begins within 3 days after cardiotoxin injection [29], we
measured myogenin expression during the first week following
injection. Although the pattern of myogenin expression is similar
for control and a-KO mice (present from day 1, peaking at day 4,
then diminishing at day 7) the myogenin levels in a-KO muscle
are lower than the control at each time point (Figure 2A).
Myogenin is also expressed at much lower levels in the PBS-
injected TA muscle of both C57 and a-KO (Figure 2B). When the
myogenin levels in the regenerating muscle are normalized to the
contralateral PBS control, the difference in early expression
becomes clear (Figure 2B). One day after injection, the ratio of
myogenin in cardiotoxin-treated to PBS injected muscle in a-KO
mice is less than 25% that of control mice. This implies that
regeneration is delayed in a-KO mice compared with wild-type
mice. Supporting this conclusion is the expression of b-actin, a
regeneration marker in skeletal muscle [30]. b-Actin is expressed
at much lower levels in a-KO mice compared with wild-type mice
at 1 day after cardiotoxin injection (Figure 2B).
a-Syntrophin modulates myogenin expression in
myogenic cell lines
To complement these studies of a-syntrophin and myogenin
expression in vivo, we used cultured cell lines that could be further
manipulated. Both the C2 cell line, isolated from adult mouse
skeletal muscle [31], and the Sol8 line isolated from mouse
oxidative (soleus) muscle [32] were used for these studies. One
difference between these lines is that Sol8 cells do not express
dystrophin [33]. In Duchenne muscular dystrophy the absence of
dystrophin leads to a large reduction of the dystrophin associated
proteins [34–36]. Sol8 cells do not express a-sarcoglycan, one of
the dystrophin-associated proteins [33], but there have been no
reports of the expression of syntrophins in these cells. Therefore,
we examined the expression of a-syntrophin during the differen-
tiation of C2 and Sol8. Before differentiation induction (0 h), the
level of a-syntrophin is similar in both cell lines. However, the level
of a-syntrophin dramatically increases in the differentiating C2
myotubes (Figure 3A). In contrast, the level of a-syntrophin in Sol8
cells does not increase during differentiation. As a control, the level
of creatine kinase, a muscle specific protein and late differentiation
marker, is similar in both lines after 96 h (Figure 3A). We also
examined the expression of myogenin during differentiation. At
time 0 h myogenin is undectable in both C2 and Sol8 myoblasts.
However, 24 h after differentiation induction myogenin can be
detected in C2 cells but not in Sol8 cells. Myogenin was eventually
detected at 36 h in Sol8 cells indicating a delay in expression of
approximately 12 h compared to C2 cells (Figure 3B).
We also performed a knock-down experiment by transient
transfection with an a-syntrophin-specific siRNA. C2 myoblasts
were transfected with control siRNA or a-syntrophin-specific
siRNA for 6 h. The transfected cells were transferred into
differentiation medium and harvested for analysis at the indicated
times (Figure 4A). The expression of a-syntrophin is greatly
reduced in the a-syntrophin-specific siRNA-transfected cells
(Figure 4), compared with the control siRNA-transfected cells.
The control cells show an increase in a-syntrophin expression
during differentiation similar to that of non-transfected cells (see
Figure 3). Myogenin is detected at 24 h in both control and a-
syntrophin specific siRNA-transfected cells, but the level of
myogenin in the a-syntrophin siRNA-transfected cells is signifi-
cantly reduced (approximately 20% of control). The reduction of
myogenin by a-syntrophin siRNA is dose-dependent. The
expression of myogenin decreases with increasing dose of the
transfected siRNA (Figure 4B).
The lower expression of myogenin could be caused by reduced
levels of transcription or by post-transcriptional mechanisms. To
differentiate between these possibilities, we measured the relative
myogenin mRNA levels using RT-PCR (Figure 4C). The
myogenin mRNA level is reduced in the a-syntrophin siRNA-
transfected C2 cells. This result indicates that the reduction of
myogenin in the a-syntrophin siRNA-transfected cells most likely
occurs at the transcriptional level.
Based on the strong relationship between a-syntrophin and
myogenin expression, we hypothesized that artificially increasing
the expression of a-syntrophin in Sol8 cells could increase
myogenin expression to that observed in C2 cells (see Figure 3A).
We tested this hypothesis by transfecting Sol8 myoblasts with
pcDNA or pcDNA-a-syntrophin. After transferring the transfected
cells into differentiation medium (0 h), cells were harvested at the
indicated time points and the expression of a-syntrophin and
myogenin assayed by immunoblotting (Figure 5). The expression
level of a-syntrophin increases with differentiation time in pcDNA-
a-syntrophin-transfected cells but remains constant in the control
(pcDNA-transfected) cells (Figure 5A). Myogenin is detected at the
24 h point in pcDNA-a-syntrophin-transfected cells; 12 h earlier
than in pcDNA-transfected cells or in non-transfected control Sol8
cells (see Figure 3B). Myogenin expression increases in a dose-
dependent manner with increasing concentration of pcDNA-a-
syntrophin (Figure 5B). RT-PCR analysis shows that transfection
of pcDNA-a-syntrophin increases the myogenin mRNA levels.
Together these data confirm our hypothesis that increasing levels
of a-syntrophin in Sol8 cells leads to a corresponding increase in
myogenin levels and that this increase is most likely due to an
increase in transcription.
Although a-syntrophin is a dominant isoform in skeletal
muscle, other types of syntrophin are also expressed in skeletal
muscle. Therefore, we examined a possibility that these other
isoforms could compensate for the absence of a-syntrophin in
regulating myogenin expression in C2 cells. In the differentiating
myoblasts, b1-syntrophin is detected only in the fully differen-
tiated myotubes (96 h) but not in the undifferentiated myoblasts
(0 h). In contrast, the expression of b2-syntrophin occurs both in
myoblasts and myotubes without significant changes in the level
( F i g u r e6 A ) .W ee x a m i n e de x p r e s s i o no fb2-syntrophin in the a-
syntrophin-specific siRNA-transfected cells (Figure 6B). b2-
Syntrophin is increased with decreasing level of a-syntrophin
by transfection. However, the increased b2-syntrophin does not
prevent the decrease of myogenin. This result implies that b2-
syntrophin does not compensate for the absence of a-syntrophin
in regard to myogenin expression. To confirm the observation,
we compared myogenin expression in the primary cultured
myoblasts from the a-KO and a/b2-syntrophin double knockout
mouse (aabb) [23]. There is no significant difference in the
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these mice (Figure 6C).
Nuclear localization of a-syntrophin
If a-syntrophin directly modulates myogenin transcription, one
would expect to find a-syntrophin in the myocyte nucleus. In
mature muscle, a-syntrophin is primarily localized at the sarcolem-
ma in association with dystrophin [37–38]. However, a-syntrophin
has been observed in the nuclear region of cultured muscle cells
[39]. We used both biochemical and immunofluorescence tech-
niques to examine the subcellular localization of a-syntrophin in C2
and Sol 8 cells. Cytoplasmic and nuclei enriched fractions were
prepared by centrifugation from cell samples acquired at 12 hr
increments following induction of differentiation. As expected, a-
Figure 2. Expression of myogenin in regenerating muscle. (A) The tibialis anterior (TA) muscles of wild type (-N-) and a-KO (-#-) mice were
injected with cardiotoxin (CTX) to induce regeneration. After the indicated number of days following injection, muscles were harvested and
myogenin expression was assayed by western blot and the band intensity was quantified using Scion Image. The intensity of the myogenin band
from the wild type at 1 day is represented as 1.00 and the other bands are expressed relative to this band. (B) Ratio of myogenin expression in the
CTX injected to the contralateral PBS-injected TA muscle at the indicated days after injection. Values are expressed as the mean 6 S.E.M. of three
independent experiments. (*p,0.005, **p,0.01). The ratio of myogenin band intensity from a-KO at 1 day was represented as 1.00. b-Actin was used
as a regeneration marker and GAPDH was used as a loading control. The black and white bars indicate wild type and a-KO, respectively.
doi:10.1371/journal.pone.0015355.g002
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syntrophin is also present in the nuclear fraction of the C2 myocytes
(Figure 7A). The amount of a-syntrophin in the nuclear fraction
increased during differentiation of the C2 cells. In contrast, only
very low levels of a-syntrophin are observed in the nuclear fraction
of Sol8 cells (Figure S2). Immunofluorescence studies of both C2
and Sol8 cells show that while a-syntrophin is found throughout the
cytoplasm, areas of concentration are present in the nucleus of C2
myoblasts. The nuclear a-syntrophin increases in the differentiated
C2 myotubes (arrowheads in Figure 7B). In contrast, very little
nuclear a-syntrophin is observed in the Sol8 myoblasts and
myotubes (Figure S2).
a-Syntrophin associates with MLL-5
The expression of muscle regulators, including myogenin, is
regulated by the histone methyltransferase, myeloid/lymphoid or
mixed-lineage leukemia 5 (MLL5) [40]. Since our results showed
that a-syntrophin expression also regulates myogenin expression
and that a-syntrophin is present in the myocyte nucleus, we
hypothesized that a-syntrophin may be associated with MLL5 in
these cells. To test this hypothesis we compared the expression of
MLL5 and a-syntrophin in differentiating C2 myocytes (Figure 7A).
MLL5 is detected in undifferentiated myoblasts (0 h) and at 48 h,
but is absent 96 h after differentiation induction (Figure 8A). Also at
the indicated time points we immunoprecipitated a-syntrophin and
tested the immunocomplexes for MLL5 (Figure 8B). The MLL5
band is detected only at the 48 h time point implying that a-
syntrophin and MLL5 associate transiently during the time when
myoblasts are undergoing differentiation. This result suggests that
the interaction of MLL5 and a-syntrophin is regulated in a time-
specific manner during myogenic differentiation.
Discussion
In mature skeletal muscle, a-syntrophin associates with
dystrophin to provide scaffolding that localizes to the sarcolemma
various channels, kinases and signaling proteins [9–11,13–17].
The a-syntrophin scaffolding has been extensively studied in
mature skeletal muscle both at the neuromuscular junction and on
the sarcolemma [41]. However, the function of a-syntrophin
during early development of skeletal muscle has not been
previously characterized. In this work we find that in addition to
sarcolemmal scaffolding, a-syntrophin functions to modulate the
expression of myogenin in differentiating muscle. We used a
variety of experiments to demonstrate that both the time-course
and the amount of myogenin expression depend on the level of a-
syntrophin expression.
Our results show that the absence of a-syntrophin leads to
reduced and delayed expression of myogenin. We observed this
Figure 3. Myogenin expression in Sol8 and C2 cell lines. (A) The
expression of dystrophin, a-syntrophin, and creatine kinase was
assessed by western blotting in C2 and Sol8 myocytes before (0 h)
and after (96 h) differentiation to myotubes. (B) Myogenin expression
assessed by western blotting at the indicated time points following
differentiation induction. Actin was used as a loading control. Results
are representative of three independent experiments.
doi:10.1371/journal.pone.0015355.g003
Figure 4. siRNA knock-down of a-syntrophin suppresses
myogenin expression in C2 cells. (A) C2 myoblasts were transfected
with control siRNA or a-syntrophin-specific siRNA. Cells were transferred
into differentiation medium and harvested at the indicated times. The
expression of a-syntrophin or myogenin was assessed by western
blotting. (B) Cells were transfected with increasing doses of control or a-
syntrophin-specific siRNA and harvested 24 h after differentiation
induction. Cell lysates were analyzed for expression of a-syntrophin
and myogenin by western blotting. Actin was used as a loading control.
(C) C2 cells transfected with control or a-syntrophin-specific siRNA
(100 nM) were assayed for mRNA levels of a-syntrophin and myogenin
by RT-PCR. GAPDH was used as a control. Results are representative of
at least three independent experiments.
doi:10.1371/journal.pone.0015355.g004
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isolated from the a-syntrophin null mice. Similarly we observed
reduced and delayed expression of myogenin in cultures of a-
syntrophin siRNA treated C2 cells. The siRNA results are
particularly interesting because they show that the level of
myogenin expression is dependent on the concentration of siRNA
used. During differentiation of Sol8 cells (a cell line that expresses
only low levels of a-syntrophin compared to those in C2 cells),
myogenin expression is reduced and delayed. Taken together,
these experiments demonstrate that reduced a-syntrophin leads to
reduced expression of myogenin. We have also observed reduced
myogenin levels in vivo during regeneration of muscle from a-
syntrophin null mice. This finding is consistent with a published
report of muscle performance in the regenerating muscle of a-KO
mice [20]. This study found that shortly after regeneration (7 days
after cardiotoxin injection) the grip strength of a-syntrophin
knockout mice was significantly less than that of control mice. This
observation implies that regeneration is slower in the absence of a-
syntrophin, a finding consistent with our observed reduced and
delayed myogenin expression in differentiating myoblasts.
Conversely, we find that over-expression of a-syntrophin
enhances myogenin expression. Primary myocytes isolated from
transgenic mice expressing high levels of a-syntrophin (on the a-
syntrophin null background) show a high level of myogenin
expression during differentiation. Likewise, differentiating Sol8
myocytes have much higher levels of myogenin when transfected
with pcDNA-a-syntrophin, a construct expressing a-syntrophin.
This increase in myogenin expression is also dose-dependent.
These in vitro and in vivo experiments clearly demonstrate a direct
correlation between the expression of a-syntrophin and myogenin
in differentiating myoblasts. This correlation is most pronounced
during the early stages of muscle differentiation. Muscles of a-
syntrophin null mice mature and function normally in the adult
mouse [22,42]. However, functional muscle regeneration is slower
in the absence of a-syntrophin [20]. These observations suggest
that a-syntrophin is not required for myogenin expression and
myoblast differentiation. Rather, a-syntrophin modulates myo-
genin expression during a critical time in the early stages of
differentiation.
Figure 5. Over-expression of a-syntrophin promotes myogenin
expression in Sol8 cells. (A) Sol8 myoblasts were transfected with
pcDNA (control) or pcDNA containing full-length a-syntrophin DNA.
Transfected cells were transferred to differentiation medium, harvested
at the indicated time points, and the expression of a-syntrophin and
myogenin determined by western blotting. (B) Sol8 cells were
transfected with increasing doses of pcDNA (mock) or pcDNA
containing full-length a-syntrophin DNA and incubated in differentia-
tion medium for 24 h. Expression of a-syntrophin and myogenin was
assessed by western blotting. Actin was used as a loading control. (C)
Transfected Sol8 cells (using 0.8 mg of DNA) were cultured for 24 h in a
differentiation medium. The mRNA levels of a-syntrophin and
myogenin were assayed by RT-PCR. GAPDH was used as a control.
Results are representative of at least three independent experiments.
doi:10.1371/journal.pone.0015355.g005
Figure 6. b2-Syntrophin does not contribute to the regulation
of myogenin expression. (A) The expression of b1-syntrophin, b2-
syntrophin, as well as a-syntrophin was determined by western blotting
in C2 undifferentiated myoblasts (0 h) and differentiated myotubes
(96 h). Actin represents a loading control. (B) C2 myoblasts were
transfected with increasing dose of control siRNA or a-syntrophin-
specific siRNA and harvested 24 h after differentiation induction.
Expression of a-, b1- and b2-syntrophins was determined with
previously characterized antibodies. Actin represents a loading control.
(C) Primary cultured skeletal muscle cells from a-KO and aabb (a/b2-
syntrophin double knockout) were harvested at the indicated time after
differentiation induction. The expression level of myogenin was
determined western blotting and band intensity was measured using
Scion Image software. The band intensities were expressed as the ratio
of myogenin to actin. Results are representative of at least three
independent experiments.
doi:10.1371/journal.pone.0015355.g006
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we determined myogenin mRNA levels during differentiation. In
a-syntrophin siRNA-treated C2 myocytes, the levels of myogenin
mRNA are reduced, similar to the protein levels. Furthermore, we
observed that in Sol8 cells overexpressing a-syntrophin, myogenin
mRNA levels were increased. These results suggest that a-
syntrophin levels modulate the amount of myogenin mRNA. This
modulation most likely occurs via an affect on myogenin
transcription, although we have not ruled out a change in
myogenin mRNA stability/turnover. However, we do find a-
syntrophin in the nuclei of differentiating myocytes at a time
consistent with transcriptional regulation of myogenin. Nuclear
localization of a-syntrophin has been previously reported in
C2C12 muscle cells [39]. Furthermore, the level of a-syntrophin in
the nucleus of C2C12 myocytes increases following induction of
muscle differentiation [39]. The primary sequence of a-syntrophin
does not contain a conventional nuclear localization signal
sequence and we do not know how a-syntrophin is directed to
the nucleus. However, since a-syntrophin is present in the nucleus
and is known to bind multiple proteins involved in cell signaling,
we propose that a-syntrophin is involved in nuclear signaling that
results in modulation of myogenin transcription.
One pathway that regulates myogenin transcription involves the
histone methyltransferase MLL5. MLL5 is part of a multiprotein
complex that regulates transcription at the epigenetic level by
mechanisms such as chromatin remodeling and histone modifica-
tion [43–44]. Expression of several regulators of muscle differen-
tiation, including myogenin, are impaired when MLL5 expression
is reduced by siRNA [40]. We hypothesized that syntrophin could
be part of the multiprotein complex associated with MLL5. We
find that MLL5 co-purifies with a-syntrophin in the specific stages
of differentiation when differentiation of myoblasts is being
initiated. Thus, a-syntrophin may regulate myogenin expression
by association with MLL5, perhaps providing a nuclear scaffold to
organize a multiprotein signaling complex.
Our results demonstrate a novel function for a-syntrophin as a
positive regulator early in the differentiation of myoblasts. a-
Syntrophin enhances myoblast differentiation and muscle devel-
opment by promoting myogenin expression. We have shown that
a-syntrophin is part of a nuclear protein complex that includes
MLL5, a known regulator of myogenin expression. Future studies
will focus on identifying other proteins in the complex and
other pathways whereby a-syntrophin modulates muscle protein
expression.
Supporting Information
Figure S1 Myoblast fusion in C2 cells and Sol8 cells. Both C2
and Sol8 myoblasts were induced to differentiate by transferring
into 5% horse serum-containing differentiation medium (time 0 h).
Figure 7. a-Syntrophin is localized in the nuclei of differenti-
ating C2 myotubes. (A) The nuclear fraction was separated from the
cytoplasmic fraction of C2 cells at the indicated times after
differentiation induction. Western blotting shows that a-syntrophin is
present in both fractions but expression increases in the C2 nuclear
fraction with differentiation. GAPDH and histone were used as markers
for cytoplasm and nuclear fractions, respectively. (B) Immunofluores-
cence of a- s y n t r o p h i ni nu n d i f f e r e n t i a t e dm y o b l a s t s( 0h )a n d
differentiated myotubes (96 h) of C2 cells shows its presence in the
nucleus. Propidium iodide (PI) staining marks nuclei. Arrowheads
indicate nuclear localization of a-syntrophin in C2 myoblasts and
myotubes. Scale bar =10 mm.
doi:10.1371/journal.pone.0015355.g007
Figure 8. a-Syntrophin association with MLL5. (A) C2 myoblasts
were induced to differentiate and the expression of MLL5 and a-
syntrophin was assessed by western blot at the indicated time points.
b-Actin is used as a loading control. (B) At the indicated differentiation
times, C2 cells were harvested and the extracts immunoprecipitated
using an anti-a-syntrophin antibody. MLL5 amount was assessed by
western blot. The ‘‘bead’’ lane refers to a control lacking the IP antibody
(a-syntrophin) and the ‘‘total’’ lane refers to a cell extract collected at
0 h. Results are representative of three independent experiments.
doi:10.1371/journal.pone.0015355.g008
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PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e15355(A) C2 and Sol8 cells were stained with hematoxylin and observed
by microscopy at the indicated times following differentiation
induction. Scale Bar =20 mm. (B) Degree of cell fusion in 10
randomly chosen fields was determined at the indicated culture
times. Values are expressed as mean 6 S.E.M. of three
independent experiments. (**p,0.01). Cells were considered to
be fused only if there was clear cytoplasmic continuity and at least
three nuclei present within the myotubes.
(TIF)
Figure S2 The subcellular localization of a-syntrophin in Sol8.
(A) The nuclear fraction was separated from the cytoplasmic
fraction in Sol8 cells at the indicated times after differentiation
induction. The level of a-syntrophin was assessed by western blot.
GAPDH and histone were used as markers for cytoplasm and
nuclear fractions, respectively. (B) Immunofluorescence of a-
syntrophin in undifferentiated myoblasts (0 h) and differentiated
myotubes (96 h) of Sol8 cells shows minimal presence of a-
syntrophin in the nucleus. PI staining marks nuclei. Scale bar
=10mm.
(TIF)
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